The high prevalence of anxiety disorders, along with the high rate of assoc
iated comorbidity, lends to significant financial burden and human sufferin
g, making early detection and proper intervention a clinical priority for t
hese conditions. Despite advances in the understanding and treatment of anx
iety disorders, a number of factors diminish the likelihood that people wit
h anxiety will benefit from these advances. The authors discuss current iss
ues relating to the treatment of anxiety disorders. This review highlights
the need for recognition of comorbid conditions, the importance of reducing
the high rates of partial treatment response, the importance of being awar
e of the common utilization of alternative treatment interventions, and the
need to recognize and treat medication-induced sexual dysfunction.